Literature DB >> 31049609

Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla.

Leah A Gilligan1, Jonathan R Dillman1,2, Jean A Tkach1, Stavra A Xanthakos3, Jacqueline K Gill1, Andrew T Trout4,5.   

Abstract

BACKGROUND: T1 relaxation time is a potential magnetic resonance imaging (MRI) biomarker for fibrosis and inflammation of the solid abdominal organs. However, normal T1 relaxation times of the solid abdominal organs have not been defined for children.
OBJECTIVE: The purpose of this study was to measure T1 relaxation times of the liver, pancreas and spleen in healthy children.
MATERIALS AND METHODS: This was an institutional review board-approved study of a convenience sample of prospectively recruited, healthy children ages 7 to 17 years undergoing research abdominal MRI (1.5 or 3 T) as part of a larger research study between February 2018 and October 2018. For the current study, T1 mapping was performed with a Modified Look-Locker sequence covering the upper abdomen. A single reviewer placed freehand regions of interest on the T1 parametric maps in the liver, pancreas and spleen, inclusive of as much parenchyma as possible. Student's t-tests and linear regression were used to compare T1 values by age and gender.
RESULTS: Thirty-two participants were included (16 female:16 male; mean age: 12.2±3.1 years; n=16 at 1.5 T). Median T1 relaxation times (ms) per organ were liver: 581±64 (1.5 T), 783±88 (3 T); pancreas: 576±55 (1.5 T), 730±30 (3 T), and spleen: 1,172±71 (1.5 T), 1,356±87 (3 T). T1 values were not statistically significantly different between males and females. At both 1.5 and 3 T field strengths, linear regression showed no significant association between age and T1 values for the liver, pancreas and spleen.
CONCLUSION: We report normal T1 relaxation times for the liver, pancreas and spleen at 1.5 and 3 T in a cohort of healthy children.

Entities:  

Keywords:  Children; Liver; Look-locker; Magnetic resonance imaging; Pancreas; Spleen; T1 mapping

Mesh:

Year:  2019        PMID: 31049609     DOI: 10.1007/s00247-019-04411-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  29 in total

Review 1.  T1 Mapping: Basic Techniques and Clinical Applications.

Authors:  Andrew J Taylor; Michael Salerno; Rohan Dharmakumar; Michael Jerosch-Herold
Journal:  JACC Cardiovasc Imaging       Date:  2016-01

2.  Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.

Authors:  Julian A Luetkens; Sabine Klein; Frank Träber; Frederic C Schmeel; Alois M Sprinkart; Daniel L R Kuetting; Wolfgang Block; Frank E Uschner; Robert Schierwagen; Kanishka Hittatiya; Glen Kristiansen; Juergen Gieseke; Hans H Schild; Jonel Trebicka; Guido M Kukuk
Journal:  Radiology       Date:  2018-06-26       Impact factor: 11.105

3.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

4.  T1 mapping for diagnosis of mild chronic pancreatitis.

Authors:  Temel Tirkes; Chen Lin; Evan L Fogel; Stuart S Sherman; Qiushi Wang; Kumaresan Sandrasegaran
Journal:  J Magn Reson Imaging       Date:  2016-08-13       Impact factor: 4.813

5.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

6.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

7.  Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.

Authors:  Michael Pavlides; Rajarshi Banerjee; Elizabeth M Tunnicliffe; Catherine Kelly; Jane Collier; Lai Mun Wang; Kenneth A Fleming; Jeremy F Cobbold; Matthew D Robson; Stefan Neubauer; Eleanor Barnes
Journal:  Liver Int       Date:  2017-05-30       Impact factor: 5.828

8.  Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.

Authors:  Zhi-Peng Zhou; Li-Ling Long; Wei-Jia Qiu; Ge Cheng; Li-Juan Huang; Teng-Fei Yang; Zhong-Kui Huang
Journal:  BMC Med Imaging       Date:  2017-03-01       Impact factor: 1.930

9.  Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR.

Authors:  Rocio Hinojar; Lucy Foote; Eduardo Arroyo Ucar; Thomas Jackson; Andrew Jabbour; Chung-Yao Yu; Jane McCrohon; David M Higgins; Gerry Carr-White; Manuel Mayr; Eike Nagel; Valentina O Puntmann
Journal:  JACC Cardiovasc Imaging       Date:  2014-12-10

10.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.

Authors:  Vanessa M Ferreira; Stefan K Piechnik; Erica Dall'Armellina; Theodoros D Karamitsos; Jane M Francis; Ntobeko Ntusi; Cameron Holloway; Robin P Choudhury; Attila Kardos; Matthew D Robson; Matthias G Friedrich; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2014-05-23       Impact factor: 5.364

View more
  5 in total

1.  Normal Liver Stiffness Measured with MR Elastography in Children.

Authors:  Andrew T Trout; Sudha A Anupindi; Michael S Gee; Geetika Khanna; Stavra A Xanthakos; Suraj D Serai; Masoud Baikpour; Juan S Calle-Toro; Arinc Ozturk; Bin Zhang; Jonathan R Dillman
Journal:  Radiology       Date:  2020-09-22       Impact factor: 11.105

2.  Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.

Authors:  Konstantinos C Fragkos; María Claudia Picasso Bouroncle; Shankar Kumar; Lucy Caselton; Alex Menys; Alan Bainbridge; Stuart A Taylor; Francisco Torrealdea; Tomoko Kumagai; Simona Di Caro; Farooq Rahman; Jane Macnaughtan; Manil D Chouhan; Shameer Mehta
Journal:  Nutrients       Date:  2020-07-19       Impact factor: 5.717

3.  Validation and feasibility of liver T1 mapping using free breathing MOLLI sequence in children and young adults.

Authors:  Yeon Jin Cho; Woo Sun Kim; Young Hun Choi; Seul Bi Lee; SeungHyun Lee; Jung-Eun Cheon; MunYoung Paek; SeungTae Woo
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

Review 4.  Survey of water proton longitudinal relaxation in liver in vivo.

Authors:  John Charles Waterton
Journal:  MAGMA       Date:  2021-05-12       Impact factor: 2.310

5.  Liver perfusion MRI in a rodent model of cirrhosis: Agreement with bulk-flow phase-contrast MRI and noninvasive evaluation of inflammation in chronic liver disease using flow-sensitive alternating inversion recovery arterial spin labelling and tissue T1.

Authors:  Manil Dinesh Chouhan; Rajiv Ramasawmy; Alan Bainbridge; Adrienne Campbell-Washburn; Steve Halligan; Nathan Davies; Simon Walker-Samuel; Mark F Lythgoe; Rajeshwar Prosad Mookerjee; Stuart Andrew Taylor
Journal:  NMR Biomed       Date:  2020-10-07       Impact factor: 4.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.